• About
  • FinancialVu Network
  • Register
  • Log In

FinancialVu

Market News and Views

  • Home
  • Commodities
  • Economics
  • Personal Finance
  • Other Articles
  • Reading List
  • Resources
You are here: Home / Archives for MarketWatch.com - Top Stories

Dow Jones Newswires: China’s economy slows to 4.9% growth in Q3, but still beats expectations

October 18, 2023 by MarketWatch.com - Top Stories

The Chinese economy grew 4.9% from a year earlier in the third quarter of the year, slowing from the growth rate in the previous quarter as the headline growth figure was hurt by a high base comparison with the same period a year earlier.

Filed Under: Top Stories

Dow Jones Newswires: China’s consumption improves, investment cools in September

October 18, 2023 by MarketWatch.com - Top Stories

China’s consumption improved in September, while investment cooled and industrial production was steady, as Beijing stepped up efforts to stimulate growth.

Filed Under: Top Stories

Dow Jones Newswires: China’s BYD forecasts higher third-quarter profit on record EV sales

October 18, 2023 by MarketWatch.com - Top Stories

Chinese automaker BYD Co. expects third-quarter profit to rise at least 67% on the back of record electric-vehicle sales.

Filed Under: Top Stories

: Elon Musk’s X to start charging new, unverified users in test program in two countries

October 18, 2023 by MarketWatch.com - Top Stories

X, formerly known as Twitter, said Tuesday it will test the new “Not a Bot” program in New Zealand and the Philippines.

Filed Under: Top Stories

Dow Jones Newswires: Takeda trial for Crohn’s Perianal Fistulas treatment misses primary endpoint

October 18, 2023 by MarketWatch.com - Top Stories

Takeda said Tuesday its trial of darvadstrocel in the treatment of complex Crohn’s Perianal Fistulas didn’t meet its primary endpoint based on topline data.

Filed Under: Top Stories

: Ardelyx wins long battle for FDA approval of kidney-disease treatment 

October 17, 2023 by MarketWatch.com - Top Stories

Drug previously rejected by regulators gets green light and is set to launch later this year

Filed Under: Top Stories

Dow Jones Newswires: Impact Biomedical files for IPO

October 17, 2023 by MarketWatch.com - Top Stories

Impact Biomedical has filed for an initial public offering, according to a filing with the Securities and Exchange Commission.

Filed Under: Top Stories

The Ratings Game: ‘Unprecedented’ AI server buildout may be happening too quickly, this analyst warns

October 17, 2023 by MarketWatch.com - Top Stories

Forecast for data-center server growth exceeds any that occurred during the rise of the internet, so while long-term is positive, risk of overbuilding is high.

Filed Under: Top Stories

Therese Poletti’s Tech Tales: AI stole the show this year, but earnings will drag Wall Street back to reality

October 17, 2023 by MarketWatch.com - Top Stories

Companies are beefing up spending on their own AI capabilities, all while AI revenues largely have yet to materialize

Filed Under: Top Stories

Earnings Results: United Airlines’ stock falls after bleak outlook for end of the year

October 17, 2023 by MarketWatch.com - Top Stories

United guided for lower profits at the end of the year because of the Hamas-Israel war.

Filed Under: Top Stories

  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 1275
  • Next Page »

Recent Articles

Starboard may be poised to build value amicably at contract research firm Fortrea

Activist Starboard Value recently disclosed a position in Fortrea Holdings. The … [Read More...]

  • High rates are historically bad for bitcoin. Here’s what’s in store for crypto with the 10-year near 5%
  • Stocks like Nvidia have ‘earnings upside’ ahead of quarterly reports, Wall Street analysts say
  • Israel-Hamas war live updates: First aid trucks enter Gaza from Egypt; Palestinian leader says ‘we will remain on our land’

Follow Us Online

  • Twitter

Copyright © 2026 · News Pro Theme on Genesis Framework · WordPress · Log in